Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Levobunolol hydrochloride 0.5% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levobunolol hydrochloride 0.5% solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levobunolol hydrochloride 0.25% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levobunolol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levobunolol hydrochloride 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levobunolol hydrochloride 0.5% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levobunolol hydrochloride 0.5% conventional release eye drops |
Has precise active ingredient |
False |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levobunolol hydrochloride 0.5% conventional release eye drops |
Has basis of strength substance (attribute) |
False |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levobunolol hydrochloride 5 mg/mL eye drops |
Has basis of strength substance (attribute) |
True |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levobunolol hydrochloride 5 mg/mL eye drops |
Has precise active ingredient |
True |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levobunolol hydrochloride 5 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levobunolol hydrochloride 5 mg/mL eye solution |
Has precise active ingredient |
True |
Levobunolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |